Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists
2001

Protecting Salivary Glands from Radiation Damage

publication Evidence: moderate

Author Information

Author(s): Coppes R P, Zeilstra L J W, Kampinga H H, Konings A W T

Primary Institution: Department of Radiation and Stress Cell Biology, University of Groningen

Hypothesis

Can pretreatment with adrenergic or muscarinic receptor agonists reduce radiation damage to the parotid gland?

Conclusion

The study found that certain drug pretreatments can reduce radiation damage to the parotid gland, especially when using a combination of methacholine and phenylephrine.

Supporting Evidence

  • The study monitored parotid salivary flow rate and cell changes for up to 240 days post-irradiation.
  • Four distinct phases of gland function were identified after radiation exposure.
  • Drug pretreatments were effective in reducing radiation effects during the early phases.

Takeaway

This study shows that giving certain medicines before radiation can help protect the salivary glands in the head and neck from damage.

Methodology

Rats were irradiated and treated with various receptor agonists, with effects monitored over 240 days.

Participant Demographics

Rats were used in the study.

Digital Object Identifier (DOI)

10.1054/bjoc.2001.2038

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication